Subclinical neuropsychiatric effects of chronic low-level solvent exposure in US paint manufacturers.
In the present study, 187 workers at two US paint manufacturing plants were assessed for symptoms of painters syndrome using the Zung Depression Index, Scandinavian Questionnaire 16, and the Present State Exam. No significant associations were found between solvent exposure and total scores, although a sum of individual questions related to depression on the Present State Exam was found to be related to both health status and exposure. The clinical relevance of these findings is discussed. Overall, exposure was not associated with the constellation of symptoms characteristic of the painters' syndrome.
Bolla
K I
KI
Johns Hopkins University School of Medicine, Department of Neurology, Francis Scott Key Medical Center, Baltimore, MD 21224.
Schwartz
B S
BS
Agnew
J
J
Ford
P D
PD
Bleecker
M L
ML
D000328:Adult; D015986:Confounding Factors, Epidemiologic; D003625:Data Collection; D003866:Depressive Disorder / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D008297:Male; D009440:Neurasthenia / Q000139:chemically induced / Q000453:epidemiology; D009784:Occupational Diseases / Q000139:chemically induced* / Q000453:epidemiology; D010150:Paint / Q000009:adverse effects*; D010555:Personality Inventory; D012997:Solvents / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000209:etiology*; D014481:United States / Q000453:epidemiology
D012997:Solvents